89bio, Inc. (ETNB)

89bio Statistics

Total Valuation

89bio has a market cap or net worth of $2.21 billion. The enterprise value is $1.68 billion.

Market Cap	2.21B
Enterprise Value	1.68B

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

89bio has 148.49 million shares outstanding. The number of shares has increased by 49.45% in one year.

Current Share Class	148.49M
Shares Outstanding	148.49M
Shares Change (YoY)	+49.45%
Shares Change (QoQ)	+7.87%
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	78.79%
Float	94.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.22
P/TBV Ratio	4.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.19, with a Debt / Equity ratio of 0.07.

Current Ratio	15.19
Quick Ratio	14.17
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-78.17

Financial Efficiency

Return on equity (ROE) is -86.86% and return on invested capital (ROIC) is -52.84%.

Return on Equity (ROE)	-86.86%
Return on Assets (ROA)	-49.10%
Return on Invested Capital (ROIC)	-52.84%
Return on Capital Employed (ROCE)	-82.59%
Revenue Per Employee	n/a
Profits Per Employee	-$4.84M
Employee Count	93
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, 89bio has paid $1.35 million in taxes.

Income Tax	1.35M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +106.68% in the last 52 weeks. The beta is 1.26, so 89bio's price volatility has been higher than the market average.

Beta (5Y)	1.26
52-Week Price Change	+106.68%
50-Day Moving Average	10.52
200-Day Moving Average	9.14
Relative Strength Index (RSI)	80.16
Average Volume (20 Days)	9,354,712

Short Selling Information

The latest short interest is 15.36 million, so 10.35% of the outstanding shares have been sold short.

Short Interest	15.36M
Short Previous Month	16.38M
Short % of Shares Out	10.35%
Short % of Float	16.20%
Short Ratio (days to cover)	11.35

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-465.68M
Pretax Income	-448.86M
Net Income	-450.21M
EBITDA	-465.64M
EBIT	-465.68M
Earnings Per Share (EPS)	-$3.41

Balance Sheet

The company has $561.16 million in cash and $37.62 million in debt, giving a net cash position of $523.55 million or $3.53 per share.

Cash & Cash Equivalents	561.16M
Total Debt	37.62M
Net Cash	523.55M
Net Cash Per Share	$3.53
Equity (Book Value)	521.73M
Book Value Per Share	3.52
Working Capital	561.91M

Cash Flow

In the last 12 months, operating cash flow was -$439.10 million and capital expenditures -$87,000, giving a free cash flow of -$439.19 million.

Operating Cash Flow	-439.10M
Capital Expenditures	-87,000
Free Cash Flow	-439.19M
FCF Per Share	-$2.96

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

89bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-49.45%
Shareholder Yield	-49.45%
Earnings Yield	-20.40%
FCF Yield	-19.90%

Analyst Forecast

The average price target for 89bio is $22.31, which is 50.08% higher than the current price. The consensus rating is "Buy".

Price Target	$22.31
Price Target Difference	50.08%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2